Thoracoscopic Left Cardiac Sympathetic Denervation for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia and Recurrent Implantable Cardioverter-Defibrillator Shocks

A patient presented with loss of consciousness and conversion. During an exercise test, catecholaminergic polymorphic ventricular tachycardia (CPVT) resulted in cardiac arrest. He started taking medication (a beta-blocker and flecainide) and an implantable cardioverter defibrillator (ICD) was inse...

Full description

Bibliographic Details
Main Authors: Woo-Sik Yu, Tae-Hoon Kim, Jee won Suh, Seunghwan Song, Chang Young Lee, Boyoung Joung
Format: Article
Language:English
Published: Korean Society for Thoracic and Cardiovascular Surgery 2015-06-01
Series:Korean Journal of Thoracic and Cardiovascular Surgery
Subjects:
Online Access:http://www.kjtcvs.org/journal/download_pdf.php?doi=10.5090/kjtcs.2015.48.3.220
Description
Summary:A patient presented with loss of consciousness and conversion. During an exercise test, catecholaminergic polymorphic ventricular tachycardia (CPVT) resulted in cardiac arrest. He started taking medication (a beta-blocker and flecainide) and an implantable cardioverter defibrillator (ICD) was inserted, but the ventricular tachycardia did not resolve. Left cardiac sympathetic denervation (LCSD) was then performed under general anesthesia, and the patient was discharged on the second postoperative day without complications. One month after the operation, no shock had been administered by the ICD, and an exercise stress test did not induce ventricular tachycardia. Although beta- blockers are the gold standard of therapy in patients with CPVT, thoracoscopic LCSD is safe and can be an effective alternative treatment option for patients with intractable CPVT.
ISSN:2233-601X
2093-6516